Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Can berries enhance lipitor's cholesterol lowering effects?Mebendazole 100mg price?When does canakinumab's patent expire?Complera ingredients?Stribild expiry date?
See the DrugPatentWatch profile for Complera
Complera is a brand-name HIV treatment. Its active ingredients are: - Emtricitabine - Rilpivirine - Tenofovir disoproxil fumarate [1]
Complera combines three antiretroviral medicines, each working against HIV in different ways: - Emtricitabine is a nucleoside/nucleotide reverse transcriptase inhibitor (NRTI). - Tenofovir disoproxil fumarate (converted in the body to tenofovir) is also an NRTI. - Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). [1]
Complera comes as a single tablet containing fixed doses of the three ingredients: - 200 mg emtricitabine - 25 mg rilpivirine - 300 mg tenofovir disoproxil fumarate [1]
For the ingredient list and fixed-dose composition, DrugPatentWatch tracks drug composition details for branded products like Complera: [1] Sources [1] DrugPatentWatch – Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate)
Other Questions About Complera :